Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7209972

NC(CCC1CCCCC1)C(=O)OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
EPHX1 P07099 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
IDO1 P14902 1/20 0.41
DPP4 P27487 5/20 0.41
DPP7 Q9UHL4 5/20 0.41
ALDH1A1 P00352 1/20 0.40
KCNH2 Q12809 3/20 0.40
TSHR P16473 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27546313 0.94 EPHX1 (0.46) CASP1CYP3A4CYP2C9CYP2C19EPHX1
Trifluoroacetic Acid SCHEMBL7206393 0.89 IDO1 (0.46) CASP1CYP3A4CYP2C9CYP2C19EPHX1
SCHEMBL6479809 0.81 IDO1 (0.52) CYP3A4CYP2C9CYP2C19EPHX1CTSL
Hydrochloric Acid SCHEMBL3825774 0.80 IDO1 (0.51) CYP3A4CYP2C9CYP2C19EPHX1CTSL
Hydrochloric Acid SCHEMBL7297833 0.80 IDO1 (0.51) CYP3A4CYP2C9CYP2C19EPHX1CTSL
SCHEMBL6473457 0.79 IDO1 (0.53) CYP3A4CYP2C9CYP2C19EPHX1CTSL
Trifluoroacetic Acid SCHEMBL28278079 0.79 ALPI (0.54) IDO1ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL28255326 0.79 LTA4H (0.43) CTSLIDO1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL3823025 0.78 IDO1 (0.52) CYP3A4CYP2C9CYP2C19EPHX1CTSL
Trifluoroacetic Acid SCHEMBL31372433 0.78 SLC15A1 (0.46) CYP2C9CYP2C19IDO1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030831-A4 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARM PROD INC (US) 2003-01-02 EP disclosed
US-6180759-B1 PREPARING AZACYCLOALKANOYLPSEUDOTETRAPEPTIDES COMPRISING COUPLING A DIPEPTIDE WITH A PSEUDODIPEPTIDE; FOR EXAMPLE, N-(N-ETHYL-N-(1-OXO-4-(4-PIPERIDINYL)BUTYL)GLYCYL)-(L)-ALPHA-ASPARTYL-3 -CYCLOHEXYL-(L)-ALANINEAMIDE; USE AS ANTICOAGULANTS AVENTIS PHARMACEUTICALS PRODUCTS INC. 2001-01-30 US disclosed
EP-1030831-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES Aventis Pharmaceuticals Products Inc. (US) 2000-08-30 EP disclosed
WO-1999019294-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARMACEUTICALS PRODUCTS INC. LEGAL/PATENTS (US) 1999-04-22 WO disclosed